Houston Methodist Sugarland is a clinical research site located in Sugar Land, Texas, United States 77479.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Houston Methodist Sugarland has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Pulmonary Embolism and Thrombosis, HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.
Sponsors: Boston Scientific Corporation, Daiichi Sankyo.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Houston Methodist Sugarland has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Houston Methodist Sugarland has 2 clinical trials on record, with 1 currently active. Their work covers Pulmonary Embolism and Thrombosis, HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.
Houston Methodist Sugarland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.